Recursion Pharmaceuticals, Inc. RXRX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s total assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total assets of $1.34B in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total assets increased by 2.6% year-over-year, from $1.31B to $1.34B.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s total assets has grown at a 37.6% compound annual growth rate (CAGR), from $298.59M to $1.47B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.